It is unclear whether higher thresholds of non-high-density lipoprotein cholesterol are more strongly associated with metabolic syndrome in adolescents and young adults with obesity. Therefore, authors of a new study assessed for the association using 2 established non-HDL-C cutoffs.
Authors of a new study presented at the AHA Scientific Sessions 2019 sought to determine whether cardiac biomarkers could identify patients at higher baseline risk for cardiovascular mortality or heart failure hospitalization, and whether SGLT2i can benefit this population.
The authors of a new study sought to determine whether a risk calculator could accurately determine the 7-year morbidity and mortality rates among patients with type 2 diabetes and obesity who may be considering bariatric surgery. Findings were presented at ObesityWeek 2019.
Dr James Matera from CentraState Medical Center in Freehold, NJ, names the key takeaways from his session at CRS 2018, "Addressing Your Patient's Cardiometabolic Risk: Management of Complex Hypertension Cases - Part Three."